BIOTHERYX

LIVE

Serial Number

90897381

Owner

BioTheryX, Inc.

Attorney

Stacey R. Halpern

First Use Date

Aug 19, 2024

Filing Date

Aug 23, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BIOTHERYX Trademark

Serial Number: 90897381 • Registration: 7663077

BIOTHERYX is a trademark filed by BioTheryX, Inc. on August 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

BioTheryX, Inc. (15 trademarks)

7966 Arjons Drive, Suite D
San Diego, CA 92126

Entity Type: 03

Legal Representation

Attorney of Record

Stacey R. Halpern

3,026 trademarks filed View all →

Correspondence Address

Stacey R. Halpern KNOBBE, MARTENS, OLSON & BEAR, LLP

2040 MAIN STREET, 14TH FLOOR

IRVINE, CA 92614

United States

Trademark Details

Filing Date

August 23, 2021

Registration Date

January 21, 2025

First Use Anywhere

August 19, 2024

First Use in Commerce

August 19, 2024

Published for Opposition

June 28, 2022

Goods & Services

Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, pharmaceutical preparations for restoring protein levels to treat diseases related to aberrant protein expression; none of the foregoing being pharmaceutical preparations for the treatment of anthrax, anthrax vaccines, or vaccines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 21, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Jan 21, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 30, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 30, 2024 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 25, 2024 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 25, 2024 AITU

USE AMENDMENT FILED

Aug 21, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 21, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 15, 2024 EXRA

SOU EXTENSION 2 GRANTED

Feb 14, 2024 EX2G

SOU EXTENSION 2 FILED

Feb 14, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Feb 14, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 17, 2023 EXRA

SOU EXTENSION 1 GRANTED

Aug 15, 2023 EX1G

SOU EXTENSION 1 FILED

Aug 15, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Aug 15, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 21, 2023 NOAM

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Jan 6, 2023 ETOP

POST PUBLICATION AMENDMENT - ENTERED

Oct 26, 2022 CHPB

ASSIGNED TO PETITION STAFF

Oct 26, 2022 APET

TEAS POST PUBLICATION AMENDMENT RECEIVED

Oct 21, 2022 EPPA

EXTENSION OF TIME TO OPPOSE RECEIVED

Jul 27, 2022 ETOF

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 28, 2022 NPUB

PUBLISHED FOR OPPOSITION

Jun 28, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 8, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 25, 2022 CNSA

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

May 25, 2022 LOPR

ASSIGNED TO EXAMINER

May 25, 2022 DOCK

LETTER OF PROTEST EVIDENCE FORWARDED

Apr 7, 2022 LOPT

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 8, 2022 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 8, 2022 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 8, 2022 COAR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 8, 2021 NWOS

NEW APPLICATION ENTERED

Aug 26, 2021 NWAP

Related Trademarks

More from this Owner

More in Same Class

VAXIKNOW

DDROPS BRAND BOOSTER THE SUNSHINE VITAMIN IN JUST ONE DROP LIQUID VIDAMIN D3 MOM'S CHOICE AWARDS HONORING EXCELLENCE 600 IU PER DROP A FACTOR IN THE MAINTENANCE OF GOOD HEALTH AND IMMUNE FUNCTION.* DIETARY SUPPLEMENT 100 DROPS 2.8 ML (0.09 FL.OZ)

MAMMOTH LABS

IDUSTER

MESOPOROSIL

THE BU:KEI LONGEVITY FORMULA